FDA Clinical Chemistry and Clinical Toxicology Devices Panel
- PMID: 11475293
- DOI: 10.1089/152091599317422
FDA Clinical Chemistry and Clinical Toxicology Devices Panel
Comment on
-
The FDA panel advises approval of the first continuous glucose sensor.Diabetes Technol Ther. 1999 Summer;1(2):203-4. doi: 10.1089/152091599317431. Diabetes Technol Ther. 1999. PMID: 11475294 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
